Innocan Pharma INNPF
OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Innocan Pharma (INNPF) Net Equity Issued and Repurchased (2024)

Updated

Innocan Pharma (INNPF) recorded Net Equity Issued and Repurchased of $93,000 in the year ended Dec 31, 2025, down 89.6% from $891,000 a year earlier.

Analysis

Innocan Pharma (INNPF) Net Equity Issued and Repurchased (2024) Analysis & Trends

  • Per Business Quant data, INNPF's Net Equity Issued and Repurchased was $891,000 in the year ended Dec 31, 2024 (-42.7%) and $1.56 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -966.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -5.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -283.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Innocan Pharma 5.78 Mn 1.73 Mn 4.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -123,000.00
Sep 30, 2024 395,000.00
Mar 31, 2024 619,000.00
API Access

Innocan Pharma Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=INNPF&period=max&api_key=YOUR_API_KEY